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INTRODUCTION
Diabetes mellitus is a clinical syndrome characterised by hypgerlycemia due to absolute 
or relative deficiency of insulin. Lack of insulin affects the metabolism of carbohydrate, fat and 
protein, and causes significant disturbance in water and electrolyte homeostasis. Long standing 
metabolic derangements is  frequently associated with permanent and irreversible functional 
and  structural  changes  in  the  cells  of  the  body,  the  vascular  system  being  particularly 
susceptible.
Although type I diabetes has a much lower world wide incidence then type 2 diabetes, 
the loss of quality life for those with type I diabetes in especially great due to earlier onset and 
greater degree of glycaemic exposure. 
Type I diabetes carries a substantial risk of morbidity and early mortality due to its 
complications which are numerous and affects both the macro and microvasculature.
Macrovascular complications result from accelerated atherosclerosis,  leading to early 
mortality as well as non fatal myocardial infarction, peripheral vascular disease and ischemic 
stroke.
The  microvascular  complications  also  contribute  to  diabetic  mortality  through 
nephropathy, renal failure and further contribute to burden associated with diabetes in the form 
of (retinopathy) blindness, neuropathy, lower extremity infection and amputation.
While the microvascular disease is specific of diabetes the macrovascular disease is not 
threshold specific but get accelerated. 
The acute complications are hypoglycemia, hyperglycemic emergencies and infections. 
Extensive data are available on the occurrence of type 1 diabetes mellitus in globally 
diverse population, and little is known about the geographic variation in the complication rates. 
This study has tried to find out the clinical features and presentations at the time of 
diagnosis, the prevalence of complication in type 1 diabetes mellitus both microvascular and 
macro vascular, the association of duration of diabetes with its complications. 
REVIEW OF LITERATURE
Sushrutha and Charaka the Indian Physicians during the 5th and 6th century AD were 
the First to recognise diabetes mellitus by the swectness of the urine, Aretaeus was the 1st to  
use the term diabetes. Thomas willis described it as the pissing evil.
Type I diabetes is not the common form of diabetes. Type 2 diabetes is 10 times more 
common than the type 1 diabetes. Type 1 accounts for only 5 - 10% of all diabetic population1.
The peak incidence of diabetes type 1 is between 10-14 years of age. The incidence of 
type 1 diabetes in USA for those under the age of 20 years is 13/100 000/yr and in the adult it is  
around 16/100 00 / year.
Data collected from different part of India reveal, incidence of type 1 diabetes below 15 
years of age to be 1-4% of all diabetics. As per Madras type 1 diabetes mellitus registry group 
of 1995 the incidence of type 1 diabetes was 10,5/100000 children with higher incidence in 
boys as in study showed by Ramachandran, Snehalatha Krishnaswami.
The overall prevalence of diabetes mellitus in India is 1-2%. The prevalence at type I is largely 
unknown  Patel5 et  al.,  and  Gupta  have  shown  type  I  is  uncommon  in  North  India. 
Krishnaswamy et al., and Chandra et al.,6 reported the prevalence of jeuvenile diabetes in South 
India as 0.8% of all diabetics.
In  a  study  done  at  Govt.  Childrens  Hospital,  Egmore,  during  1977  -  1982  by  TK 
Sengottuvel et al., the incidence was 22.8 / 100 000 out patient cases.
Prof. Seshiah's incidence was 160 / 100 000.
In central Kerala it was 3.61 among diabetics.
The prevalence of type 1 diabetes has been increasing in recent decades, upto twice the 
frequency every 10 years in some countries. The annual rate of increase in type 1 diabetes in 
European children under 15 years of age for 1989 - 94 was estimated a 3.4%2.  This trend 
varies from country to country. The annual incidence ranged from 3.2 to 40.2 per 100 000 in 
one report. 
The empiric risk of developing type 1 diabetes in a general population is 0.4%. The risk 
of developing type 1 diabetes mellitus in the off spring of a diabetic father is 6.1%, in the 
offspring of a diabetic mother it is 2%, in the offspring of a diabetic father and mother is 3.6%. 
In a monozygotic twin the risk is 30 - 50% in a dizyogtic twin it is 5%. Approximately 1 in 20 
first degree relatives of patients with type 1 diabetes mellitus will develop this disorder.
CLASSIFICATION3
Etiological classification of diabetes mellitus
Type 1 diabetes
β-cell destruction, usually leading to absolute insulin deficiency.
A. Immune mediated
B. Idiopathic
Type II diabetes
May range from predominantly insulin resistance with relative insulin deficiency to a 
predominantly insulin secretary detect with or without insulin resistance.
III. Other specific types of diabetes
a. Genetic  defect  of  β  cell  function  characterised  by  mutation  in  various 
genes.
b. Genetic defects in insulin action
c. Disease of exocrine pancreas
d. Endocrinopathies
e. Chemical or drug induced
f. Infection
g. Immune mediated (uncommon)
h. Other genetic syndromes associated with diabetes mellitus.
IV. Gestational diabetes mellitus
Diagnostic criteria4
Three ways to diagnose diabetes are possible, and each in the absence of unequivocal 
hyperglycemia, must be confirmed on a subsequent day, by any one of the three methods.
1. Symptoms of diabetes plus or casual plasma glucose concentration > 200 mg/dl.
Casual is defined as any time of the day, without regard to time since last meal. The 
classic symptom of diabetes include polyuria, polydipsia and unexplained weight loss.
(or)
Fasting plasma glucose  > 126 mg/dl (7.0 m.mol / lit) fasting is defined as no caloric 
intake for at least 8 hrs.
2 hours post glucose load > 200 mg/dl 11.1 m.mol / lit during an OGTT. The test should 
be performed as described by WHO, using a glucose load containing the equivalent of 75 gm 
anhydrous glucose dissolved in water.
It is differentiated from type 2 DM by the presence of the following given feature in type 
1 DM.
- Commonly develops before the age of 30
- Lean body habitus
- Propensity to develop ketosis
- An increased risk of auto immune disorder such as:
Auto immune thyroid disease
Perinicious Anaemia
Vitiligo
Addison's. disease
Aetiology and risk factor for development of type I DM.
Type 1DM is influenced by genetic and environmental factors. Type I DM is a T-cell 
mediated autoimmune disease, targets include insulin and glutamic acid decarboxylase. Over 
95% of caucasian type I DM subjects carry HLA DR3 or DR4 antigens.
 Genetic predisposition is thought to be crucial for the development of the autoimmune 
form of type 1 diabetes. 
In a recent European (EURODIAB) survey, the risk for a type 1 DM mother having a 
child with onset of diabetes before the age of 5 years was 1.8% and for father 3.4%7.
This means that in more than 90% of cases in which type I diabetes is diagnosed there is 
no other known case in the family history and these figures are reassuring to most diabetic 
people wanting to have children.
The HLA grouping of the children along with determination of anti islet and antiinsulin 
antibody can help greatly in predicting the risk of type 1 DM siblings8.
Prevalence  of  islet  cell  antibody  appears  to  be  low  in  South  India  type  1  diabetic 
population9.
Likely environmental triggers in genetically susceptible individuals include viruses and 
chemical toxins.
Viruses - coxsackie B4, Rubella, Mumps and Echovirus10.
Exposure in pregnant women to nitrosoamines in smoked meat increases the risk in 
children.
Clinical Features
Type  1DM is  diagnosed  during  sudden  appearance  of  weight  loss  1  to  2  kg/week 
accompanied by polyuria, nocturia and polydipsia in young lean subject, fatigue in later part of 
the day is always present, appetite is good or even increased.  A noticeable muscular atrophy is 
particularly visible in the thighs.
In the presence of ketosis smell of acetone in the breath may be noticed.
If the 1st time of visit reveals massive glucosuria, moderate to intense ketonuria and 
high blood glucose level > 270 mgm/dl, insulin therapy should be started on the same day.
Determination  of  antiislet  autoantibodies  allow  clear  identification  of  the  two  other 
forms of type 1 diabetes, the preclinical phase of type 1 autoimmune diabetes in the young and 
LADA.
TREATMENT
Treatment of uncomplicated type I DM classically rests on a tripod, insulin, diet and 
physical activity coherently balanced with the help of a platform of knowledge and controlled 
by frequent blood glucose monitoring, if one leg of tripod falls the equilibrium fails.
Insulin  replacement  is  clearly  the  most  important  part  of  treatment,  it  is  based  on 
mimicking the non - diabetic insulin secretion pattern, with its slow basal delivery throughout 
the entire day and boosts at the meal time.
Rapid acting insulin is injected before meals to simulate postprandial insulin secretion 
and  intermediate  or  long  acting  insulin  is  injected  once  or  twice  daily  to  simulate  basal  
delivery.
DIET
The approaches to nutrition of type 1 diabetes have radically changed in recent decades, 
more emphasis in put on the role of a well balanced, healthy, varied diet,  rich in complex 
carbohydrates  with  a  low  glycemic  index  and  high  in  fibre  with  shift  from  saturated  to 
polyunsaturated to monounsaturated fats, a certain amount of sucrose is permitted.
Ideally the patient should match the dose of preprandial insulin to the size and content of 
meals expected to follow (Carbohydrate counting).
Physical exercise and sports at least in young adults are needed more for overall health 
maintenance and physical and mental balance rather than for obtaining good blood glucose 
control.
Blood glucose self monitoring has been one other most important steps in the process of 
patient empowerment in relation to the disease.
Patient education : The patient should be clearly informed in writing using a (therapeutic 
contract) that defines and agrees the desirable goal of treatment, one of the most  challenging 
aspects is to encourage patient to stop smoking.
Acute Complications
Hypoglycemia is the main concern and burden in life of all type 1 diabetic patients and 
main obstacle  to  obtaining very  good metabolic  control,  clinical  manifestations  are  due  to 
catecholomine release or CNS manifestation.
Adrenergic  symptoms  like  perspiration,  tachycardia,  tremor,  pallor  and  uneasiness 
occurs  earlier,  CNS  manifestations  include  change  in  personality,  behaviour,  confusion, 
obtundation, convulsion and coma, nocturnal hypoglycemia may be manifested by nightmares, 
night sweats and morning head ache.
In  patient  on  insulin  treatment11 in  type  1DM  insulin  levels  cannot  decrease  with 
exercise or fasting, in Type 1 DM more than 2 years duration the glucogon response to insulin 
induced hypoglycemia is  usually  reduced and after  15 years of  diabetes the  catecholamine 
response may wane leaving the patient defenceless against hypoglycemia12.
Diabetic Ketoacidosis
Pathophysiology13
- Increased glycogenolysis and gluconeogenesis in the liver and kidney resulting in 
marked hyperglycemia.
- Insulin  lack  and  counter  regulatory  hormone  excess  activate  the  hormone 
sensitive lipase leading to lipolysis, the FFA thus released are taken to liver and 
serve as substrate for ketogenesis..
- Low  insulin  and  high  glucogen  level  in  DKA result  in  low  malonyl  CoA 
production by the hepatocytes leading to reduced entry of FFA into mitochondria.
- The end result is rapid increase in β hydroxybutyrate and acetone.
- Brain  and  skeletal  muscles  can  metabolise  ketone  bodies  normally,  but  it  is 
impaired in DKA.
- Acetoacetate and β hudroxy butyrate are strong acids and are fully associated at 
body pH consuming body buffers and resulting in acidosis.
- Marked  hyperglycemia  causes  osmotic  diuresis,  increased  extracellular 
osmolarity shifting water from cells leading to cellular dehydration.
Biochemical Mechanism of diabetic tissue damage
Chronic  tissue  damage  is  related  to  severity  and  duration  of  hyperglycemia,  tissue 
damage may continue to evolve even after hyperglycemia has been improved (hyperglycemic 
memory)14.
At cellular level hyperglycemia may damage tissue by :
- Enhanced glucose flux through the polyol pathway
- Formation of advanced glycation end products.
- Activation of protein kinase C.
- Stimulation of hexosamine pathway.
Excess mitochondrial production of reactive oxygen species and superoxide may also 
play a role.
Diabetic Retinopathy
Earliest sign of retinopathy is basement membrane thickening, Type IV collagen and 
laminin increases while heparensulphate and proteoglycan decreases6.
Pericyte loss is another feature of retinopathy. 
There  is  increased  capillary  permeability  and  leakage  resulting  in  extravasation  of 
products  from  circulation.  The  resulting  mass  of  fibrinoid  material  and  dying  lipid  laden 
macrophages are seen as hard exudates in fundoscopy.
Diabetic  Retinopathy  is  a  highly  specific  vascular  complication  of  diabetes,  the 
prevalence is strongly associated with duration of illness. After 20 years of diabetes nearly all  
patients with type 1 diabetes and >60% of type 2 diabetes have some degree of retinopathy16.
In the WINCOMIN Epidemiological study of diabetic retinopathy WESDR 3.6% of type 
1 and 1.6% of type 2 patients were legally blind17.  Vision threatening retinopathy virtually 
never appears in type 1 diabetes in the first 3 - 5 years of diabetes or before puberty.
For clinical purpose retinopathy is divided into three major groups.
1. Background retinopathy
2. Preproliferative retinopathy
3. Proliferative retinopathy
Back ground retinopathy
Micro aneurysm is the earliest evidence in about 25% of patients. Micro aneurysm of 
retinal capillaries are thought to develop subsequent to loss of supporting pericytes around the 
capillary  wall.  Other  features  include  tortuosity  of   vessels,  linear  flame  shaped  retinal 
haemorhages, hard exudate, cotton wool spots. 
Preproliferative retinopathy has multiple micro aneurysm and cotton wool spots along 
with IRMA ie intra retinal microvascular abnormality. 
Proliferative retinopathy
Hallmark of this stage is neovascularisation New vessels may arise on the optic disc or 
on retinal surface unsupported by connective tissue. Other features include glial proliferation, 
vitreous hemorrhage and retinal detachment.
Diabetic retinopathy primarily affects veins, venules and venous end of capillaries.
Other eye complication are cataract and rubeosis iridis. 
In type 1 diabetes, suggested screening schedule for retinopathy are as follows18. Need 
for screening is irrefutable.
First examination within 3 - 5 years after diagnosis of diabetes, once the patient is 10 
years or older, minimum routine follow up yearly once.
DIABETIC NEUROPATHY
The pathogenesis and progression of diabetic peripheral neuropathy are related to the 
duration  and  severity  of  hyperglycemia.  Glucose  could  damage  nerve  cells  via  increased 
glucose flux through polyol pathway, non enzymatic glycation of proteins and other longlived 
macro molecules and oxidative stress.
Pathological  features  include  distal  fibres  loss  and  demyelination  with  slowing  of 
conduction velocity which is initially reversible on correction of hyperglycemia. Myelinated 
fibres may be relatively protected, longest axon may be most affected.
In Europe and North America neuropathy occurs in approximately 20%19 individuals 
with  long  standing  diabetes.  It  may  manifest  as  polyneuropathy  mononeuropathy  and /  or 
autonomic neuropathy.
Mononeuropathies  may  involve  cranial,  truncal  or  peripheral  nerves,  cranial 
mononeuropathy commonly involve oculomotor  nerve with characteristic  pupillary  sparing, 
sixth and seventh cranial nerve palsies may also occur.
Truncal  mononeuropathy occurs  with sudden onset  of  pain with hyperaesthesia  in  a 
unilateral radicular distribution, thoracic and upper lumbar segments, which may mimic root 
pain of herpes zoster.
Peripheral  monopeuropathy  may  present  with  carpal  tunnel  syndrome  or  peroneal 
neuropathy producing sudden painless footdrop.
Most common form of polyneuropathy is distal symmetrical polyneuropathy. It presents 
with distal sensory impairment loss of ankle reflex and abnormal position and vibration sense.
Proximal motor neuropathy ie diabetic amyotrophy is more common in type 2 DM.
Neuropathy may selectively involve small fibres causing pseudo syringomyelia or large 
fibres causing pseudotabes.
Autonomic neuropathy can be detected by simple clinical tests for cardiovascular reflex 
like change in heart rate during deep breathing, standing, valsalva and blood pressure response 
to standing and sustained hand grip, patients with autonomic neuropathy are prone for sudden 
death from painless myocardial infarction.
DIABETIC  NEPHROPATHY
The pathology of diabetic kidney affects both the glomerulus and tubular interstitium. 
Glomerular  enlargement  occurs  initially  increased  capillary  length  and  increased  filtration 
surface area, followed by basement membrane thickening and mesangial expansion. 
At the time of diagnosis both glomerular and kidney volume are increased20 . Diabetes is 
the single most common cause for end stage renal disease.
About 20 - 30% patients with type 1 diabetes develop evidence of nephropathy. The 
earliest  clinical  manitestation  is  low but  abnormal  level  of  albumin in  urine  called  micro-
albuminuria (30-300 mg/day or 20 μg/mt). Patients with micro albuminuria are referred to as 
having incipient nephropathy.
Without  specific  intervention  80%  of  subjects  with  type  1  diabetes  who  develop 
sustained microalbuminuria have their urinary albumin excretion increase at a rate of 10 - 20% 
per year to the stage of overt nephropathy or clinical albuminuria (> 300 mg/24 hrs or  >200 
μg/ml) over a period of 10 - 15 years with hypertension also developing along the way.
Once overt nephropathy occurs without specific interventions, the glomerular filtration 
rate  gradually  falls  over  a  period  of  several  years  at  a  rate  that  is  highly  variable  from 
individual to individual.
ESRD develops in 50% of type 1 diabetic individual with overt nephropathy with in 10 
years and > 75% by 20 years. 
   50%
Normo albuminuria   sustained normo albuminuria
      30%  50%
____ Micro albuminuria     sustained micro albuminuria
  20%  Hypertension
? glyemic control
Intermittent proternuria
     Proteinuria
    Hypertension
      ESRD21
24 hrs Timed collection Spot collection
Normal < 30 mg/24 hr < 20 µg/mt < 30 µg/mg of cr.
Micro 
albuminuria
30 - 300 mg/24 hr 20 - 200 µg/mt 30 - 300 µg/mg of cr.
Clinical 
albuminuria
> 300 mg/24 hr > 200  µg/mt > 300 µg/mg of cr.
Because of variability of urine albumin excretion 2 or 3 specimen collected within 3 - 6 
month period should be abnormal before considering a patient to have crossed one of these  
diagnostic thresholds.
Management includes, tight glycemic control, hypertension control, ACE inhibitors and 
protein restriction. These measures play a major role in delaying ESRD. Living Donor (related) 
renal transplant is now gold standard of treatment.
MACROVASCULAR COMPLICATIONS
Lipid Alteration
Patient  with  well  controlled  type  1  diabetes  and  normal  triglyceride  level  develop 
increased  level  of  chylomicrons  and  very  low  density  lipoprotein  (VLDL)  during  insulin 
deficiency22.
Two mechanism may play role
1. Decreased level of Lipoprotein lipase with insulin deficiency produce a defect in 
lipolysis of triglyceride rich lipoproteins.
2. Increased  level  of  Free  fatty  acids  provide  substrate  for  over  production  of 
hepatic  VLDL.  Insulin  therapy  reverses  both  these  defects  and  restores 
triglyceride level to normal.
LDL (low density lipoprotein) level may be elevated in type 1 diabetes. This may be due 
to insulin deficiency causing reduced activity of LDL receptors impairing its clearance. The 
glycation and oxidation of LDL reduce its affinity for its receptors. Insulin therapy revert this to 
normal. Poorly controlled type 1 diabetes leads to increased lipolysis and over production of 
non  esterified  tatty  acids  (NEFA)  and  decrease  activity  of  lipoprotein  lipase,  the  insulin 
dependent enzyme that hydrolyses triglyceride in circulating lipoprotein.
The  result  is  hyper  triglyceridemia  severe  enough  to  cause  pancreatitis,  eruptive 
xanthoma, lipaemia retinalis. Lipid profile is nearly normal in well controlled type 1 DM.
Hypertension - It is twice as common in diabetic as in general population22.
In  type  2DM  there  is  associated  obesity,  insulin  resistance  and  other  features  of 
metabolic syndrome. In type 1 diabetes in microalbuminuria phase of diabetic nephropathy 
blood pressure rises, total body Na+ and peripheral resistance are raised. Hypertension worsens 
both macro vascular and micro vascular complications.
Effective treatment of blood pressure reduces microvascular notably, nephropathy and 
certain macrovascular events and diabetes related deaths.
CARDIOVASCULAR DISEASES
Both type 1 and type 2 diabetes increases cardiovascular risk 2 - 4 folds compared with 
general population. Cardiovascular disease kills 75% of all diabetic people and accounting for 
36% of all deaths in myocardial infarction.
The pathology is intimal thickening with atheroma formation; endothelial disease may 
cause increased adhesiveness. Impaired relaxation due to decrease NO production. Advanced 
glycation end products and impaired compliance also play a role. 
Atheroma formed in diabetes has certain special characters it is more extensive, diffuse 
and involves distal vessels23.
Coronary  artery  disease  and  hypertension  can  account  for  most  myocardial 
abnormalities in diabetes, postmortem studies showed evidence of specific cardiomyopathy in 
the absence of coronary artery atheroma.
Increased LDL predisoposes to CAD24.
Clinical manifestation of cardiovascular disease are angina, myocardial infarction, heart 
failure, dysrrythmia, peripheral and cerebrovascular disease.
Primary prevention of cardiovascular disease and risk factor management
- Life  style  management,  cessation  of  smoking,  optimizing  glycemic  control, 
management of dyslipidemia, management of hypertension and renoprotection.
Diabetes and tuberculosis25
 Tuberculosis has higher incidence in diabetes. Involvement of lower lobe is common, 
bilateral  involvement  may  also  occur.  Diabetes  reactivates  latent  tuberculosis.  Chest 
radiography should be taken once in 6 months in all diabetic patients. Tuberculosis must be 
suspected  if  there  is  an  increase  in  insulin  requirement,  associated  with  weight  loss. 
DIABETES AND PREGNANCY
Normal pregnancy itself produces few alteration in glucose metabolism26. In the early 
weaks  of  pregnancy  serum  level  of  estrogen  and  progestorone  raise  and  induce  β  cell  
hyperplasia, resulting in increased elaboration of insulin and heightened sensitivity  to insulin 
causing  low fasting  blood  sugar.  In  the  later  half  of   pregnancy  facilitated  insulin  action 
continues and at the same there is increased elaboration of counter hormones, human placental  
lactogen,  prolactin,  and  cortisol,  results  in  insulin  resistance  and  stress  on  carbohydrate 
metabolism and hence the gestational diabetes develop in later half of pregnancy.
Poorly controlled diabetes before conception and during first trimester of pregnancy can 
cause major birth defect in 5% to 10% of pregnancies and spontaneous abortion in 15 to 20% 
of pregnancies.
Poorly controlled diabetes during second and third trimester of pregnancy can result in 
excessively large babies posing risk to both mother and child.
PREVENTING DIABETIC COMPLICATION
Uncontrolled diabetes can lead to serious complications such as heart disease, blindness, 
kidney damage and lower limb amputation. Working together, people with diabetes and their 
health care providers can reduce the occurrence of these and other diabetes complications by 
controlling  the  level  of  blood  glucose,  blood  pressure  and  lipids  and  by  receiving  other 
preventive care practices in a timely manner.
Glucose Control : Improved glycemic control benefits people with both type of diabetes. 
Every one percentage drop in Hb AIc reduces risk of microvascular complication by 40%.
Blood pressure control reduces risk of cardiovascular disease in a diabetics by 33 - 50% 
and risk of microvascular complication by 33%.
Improved - control of cholesterol can reduce cardiovascular complications by 20% to 
50%.
SCREENING FOR DIABETICS27
 Most cases of type 1 diabetes are detected after development of symptoms. widespread 
clinical testing of asymptomatic individuals for the  presence of auto antibodies related to type I 
diabetes cannot be recommended at this time as means to identify person at risk. The reasons 
for this include
1. Cutoff  values  for  some  of  the  immune  marker  assay  have  not  been  completely 
established in clinical setting,
2. There is no consensus as to the action that should be taken when a positive antibody 
result is not obtained
3. Incidence of type 1 diabetes is low and testing of healthy children identify only a 
very small number (< 0.5%) who at the moment may be prediabetic. 
AIMS AND OBJECTIVES OF THE STUDY
To describe the prevalence of microvascular and macrovascular complications of type 1 
diabetes mellitus assessed by both reported and measured disease risk factors.
- To study the clinical features and presentation of type 1 diabetes mellitus.
- To analyse the association of duration of illness with its complications.
MATERIALS AND METHODS
SETTING 
Out  patient  clinic  in  the  Department  of  General  Medicine  and  Department  of 
Diabetology, Madras Medical College and Government General Hospital, Chennai - 3.
It  is  a  single  centre  cross  sectional  study of  randomly selected patients  with type 1 
diabetes mellitus.
Period of Study : August 2005 to July 2006
Twelve months duration
150 Randomly selected patients with type 1 diabetes mellitus attending the out patient 
clinic formed the material for the study.
Inclusion Criteria
1. Patient with diabetes mellitus with onset of disease at or below the age of 25.
- Requirement  of  insulin  as  the  initial  mode  of  treatment  at  the  time of 
diagnosis of diabetes.
- A member of defined community.
EXCLUSION CRITERIA
Patient of age more than 25 even if they require insulin as a mode of treatment initally 
who may belong to LADA Late Onset diabetes in adults.
The  patient  were  subjected  to  detailed  questioning  which  included,  history  of  the 
physician  diagnosed  complications.  Health  care  behaviour,  which  included  blood  glucose 
testing, insulin administration, of number of visit  to physician etc. Patient was asked about 
smoking  status,  educational  and  occupational  history,  medication  and  insulin  use,  alcohol 
consumption and family history of diabetes. Examination consists of procedure which includes 
sitting  blood  pressure  measurement  with  a  random zero  sphygomomanometer.   Following 
HDFP protocol [Hypertension detection and follow up program] with systolic and diastolic 
pressure  > 140 and 90 mmHg respectively,  or  treatment  with  antihypertensive drugs  were 
considered  positive  for  hypertension.  Height  and weight  were  recorded in  centimeters  and 
weight respectively.
Detailed cardiovascular  and neurological  histories were taken to  supplement  the  self 
reported data, cardiovascular examination were done, recording the presence of ankle edema, 
basal crepitations and peripheral pulses. Electrocardiogram was done and echocardiogram was 
done whenever necessary.
MNSI Michigan neuropathy screening instrument examination, questionnaire was used 
for testing clinical neurology. Neurological examination were done by eliciting the deep tendon 
reflexes, vibration perception at the bony prominence, sensory testing was done using a pin.  
Seven correct answers out of ten were considered normal, one to six correct responses were 
considered as reduced sensation and no correct response was considered as absent sensation.
Visual  acquity  was  measured  by  using  vision  card  and  number  of  letter  size  were 
recorded for both eyes. Fundoscopy examination was done to look for the presence of any signs 
of retinopathy.
LABORATORY ANALYSIS
Both a fasting and post prandial blood glucose level were tested. A non timed urine 
sample was taken, and tested for albumin sugar and deposits. Microalbuminuria test was done 
using the (micral) disptick testing method.
Renal function tests which included the electrolytes were done on all patients. A fasting 
lipid profile was tested, high level of cholesterol and / or triglyceride levels were considered as 
abnormal.
Glycemic  control  was  assessed  using  the  measurement  of  glycosylated  hemoglobin 
HbA1c. In a normal person the value is 3 - 6%.
DEFINITION OF END POINTS
Reported complications were defined as a self report of physician diagnosis including 
retinopathy  and  laser  treatment,  neuropathy,  kidney  problems  related  to  diabetes  and  /  or 
albumin in the urine, high cholesterol and / or triglycerides.
Mascrovascular  compliactions  including  myocardial  infarction,  stroke,  peripheral 
vascular  disease  angina  and  amputation.  MNSI  questionnaire  was  used  as  a  marker  for 
neuropathy, which consisted of 15 Yes or no questions. Possibility of neuropathy was done by 
using  bed  side  examinations.  Microalbuminuria  was  tested  using  micral  dipstick  testing 
method. 
Glycemic control
Patients  who had HbA1c less  than  7% were considered as  are  with good glycemic 
control.  
7 - 8% under moderate control.
> 8% had poor control with treatment action immediately.
Hypertension was defined in my study as systolic pressure > 140 mmHg and ddiastolic 
pressure > 90 mmHg, or patient is on antihypertensive medication.
RESULTS
AGE DISTRIBUTION
The age of patient selected for the study, 150 in number ranged from 10 years to 41 
years.
Table 1 shows the stratified age distribution of the patients studied.
TABLE : 1
Age of the patient No. of patients Percentage
≤  15 years 22 16%
16-25 years 67 45%
26-35 years 43 27%
≥  36 years 18 12%
GENDER DISTRIBUTION
Gender distribution of the 150 patients selected randomly for the study 82 were females 
and the remaining 68 males.
TABLE : 2
SHOWS GENDER DISTRIBUTION
Sex No. of patients Percentage
Male 68 45%
Female 82 55%
AGE AT DIAGNOSIS
Age of the patient at the time of diagnosis of dilates mellitus ranged from Table 3 shows 
the age wise distribution at the time of diagnosis.
TABLE : 3
Age at diagnosis No. of patients Percentage
≤  10 19 13%
11-15 64 42%
16-20 51 34%
> 20 16 16%
DURATION OF DISEASE
Duration of diahetes mellitus in the patients selected for the study ranged from 1 to 21 
years.
TABLE : 4
SHOWS DISTRIBUTION OF DURATION OF DISEASE IN YEARS
Duration of disease No. of patients Percentage
≤  5 years 44 29%
6-10 years 63 42%
11-15 years 21 14%
≥  16 years 22 15%
CAUSE FOR DETECTION OF PATIENTS
The 150 patients in the study group had varying mode of presentation at the time of 
diagnosis.
The mode of presentations were the typical symptoms of diahetes mellitus like polyuria, 
Nocturia polydipsia, polyphagia, loss of weight and increased fatiguability.
Fever, which was due to respiratory and urinary tract infections and tuberculosis.
Few  of  them  presented  with  symptoms  suggestive  of  ketosis  like  abdominal  pain, 
vomiting, nausea, altered sensorium and coma.
Other symptoms which includes pruritis valvae and balanophosthitis.
TABLE : 5
SHOWS THE PERCENTAGE OF DISEASE PRESENTATION
Symptoms No. of patients Percentage
Weight  loss  triedness  Polyuria, 
polyphagia, polydispsia
65 44%
Fever  due  to  respiratory  and  urinary 
tract infection
39 26%
Symptoms of ketosis 22 14%
Tuberculosis 9 6%
Others 15 10%
KETOSIS PRONENESS
The patients of type I diabetes mellitus are more prone to develop diabetic ketoacidosis.
Symptoms  with  which  the  patient  may  present  include  abdominal  pain,  nausea, 
vomiting, lethergy, altered sensorium and coma patient may present initially with symptoms of 
ketosis or develop ketosis atleast once during their life time.
Ketoacidosis is one of the life threatening acute complication of type I diabetes mellitus, 
early and prompt diagnosis and management brings on a dramatic recovery.
HYPO GLYCEMIA
It is one of the most commonly occurring acute complication of type I diabetes mellitus.
Significant number of patient develop hypoglycemia during the course of illness, due to 
varying causes.
The  patient  may  experience  giddiness,  sweating  palpitations,  tachycardia,  altered 
sensorium drowsiness and even coma.
Prompt diagnosis and treatment is necessary.
Table 6 shows the number of patients who had acute complications.
TABLE : 6
SHOWS PREVALENCE OF ACUTE COMPLICATIONS
Acute complications No. of patients Percentage
Ketoacidosis 49 32%
Hypoglycemia 86 57%
FAMILY HISTORY OF DIABETES MELLITUS
In type I diabetes mellitus there is a significant family history. Out of 150 patients 20 
had family history.
TABLE : 7
SHOWS VARYING DISTRIBUTION OF FAMILY HISTORY
Relatives No. of patients Percentage
Father 7 4.7%
Mother 5 3.3%
1st Degree 4 2.7%
2nd Degree 4 2.7%
Total 20 13.3%
Body mass index
BMI with calculated using the formula
BMI = weight in Kilograms Height in meter.
BMI (Body mass index)
17-25 is the normal range for women
17-24 is normal for men
<17 - under weight
25-30 over weight
>30 obesity
TABLE : 8
SHOWS THE BODY MASS INDEX OF THE STUDY GROUP
BMI No. of patients Percentage
Normal 118 78%
Under weight 19 13%
Over weight 13 9%
Other - -
PULSES
Among the 150 patients under my study, all the peripheral pulses were felt normally in 
148 persons.
BLOOD PRESSURE
Out of the 150 patients 30 persons had systemic hypertension, with almost equal gender 
distribution. 14 males and 16 females hypertension may lead to increase in the incidence of 
microvascular  complications  like  retinopathy,  neuropathy  and  rephropathy,  it  also  has  a 
significant association with the macrovascular complications.
The Table shows No. 9 of patient considered to be hypertensive. 
TABLE - 9
SHOWS THE PREVALENCE OF HYPERTENSION
No. of patients with HT Percentage
Male 14 21%
Female 15 18%
Total 29 19%
Duration of 
Disease
Total with Hypertension
PercentageMale Female Total
< 5 - - - -
6 - 10 1 - 2 3.1%
11 - 15 4 6 10 47.6%
> 16 3 4 7 77%
NEUROPATHY
Diabetic neuropathy occurs in more than 50% of patients with diabetes both in type 1 
and type 2.
TABLE - 10
SHOW THE PREVALENCE OF NEUROPATHY IN THE STUDY
Duration of 
Disease
No. of patients with neuropathy
PercentageMale Female Total
< 5 1 2 3 7%
6 - 10 9 8 17 25%
11 - 15 5 6 11 52%
> 16 6 7 13 59%
A total  of  44  persons  had  neuropathy  with  a  p  value  of  <  0.001  it  is  considered 
significant at 1% level.
RETINOPATHY
Diabetic retinopathy is estimated to be the most frequent cause of new cases of blindness 
in the persons in between the age group of 25 and 75.
Retinopathy is rare during the initial  stage of the disease, as the duration of disease 
increase the chances of having retinopathy is more.
The prevalence of retinopathy in the study group is given in the table - 113 in which 25 
of them had retinopathy.
TABLE - 11
Duration No. of patients Percentage
Male Female Total
< 5 1 0 1 2%
6 - 10 4 5 9 14%
11 - 15 5 6 11 52%
> 16 7 9 16 72%
A total at 37 persons had retinopathy value < 0.001, significant at 1% level.
NEPHROPATHY
Diabetes is the most common single disease causing renal failure progressing to end 
stage renal disease ESRD in both type 1 and type 2 diabetes mellitus.
A considerably higher fraction of them belong to type 1 disease.
TABLE - 12
SHOWS THE PREVALENCE OF  NEPHROPATHY IN THE STUDY GROUP
Duration No. of patients Percentage
Male Female Total
< 5 - - 0 -
6 - 10 1 1 2 3%
11 - 15 4 5 9 42%
> 16 7 7 14 63%
A total number of 25 persons has nephropathy p value 0.001, which in significant at 1% 
level. 
DYSLIPIDEMIA
The increased prevalence of macro vascular disease is due to accelerated atherogenic 
potential in the diabetics, dyslipidemia play a significant role in Atherogenesis although type 1 
disease contributes a smaller fraction when compared to type 2 disease.
Totally 14 persons had dyslipidemia.
4 persons had coronary artery disease which included :
3 Males  and  1 Female
Peripheral vascular disease was detected in 2 persons both of them males.
Glycemic control.
In my study glycemic control was good in most of the 117 persons patients, i.e. <7% of 
HbAIc.
In 29 patients between 7 to 8
10 patients had HbA1c more than eight. 
In my study 18 patients had microalbuminuria and 7 had clinical protienuria.
DISCUSSION
The onset of type 1 diabetes world wide most commonly occurs between the age of 10 - 
14.
In my study 64 persons were detected to have type 1 DM in the age group 11 - 15, which 
constituted 42%.
In the age group of 16 - 20 there were 51 persons, 34%.
Prevalence of type 1 diabetes is common in males than in females, peak age of diagnosis 
was 11 for girls and it was between 11 - 18 for boys. The occurrence of disease was maximal at 
11 years in urban group and 18 years in rural population Sridhar GR, Gender difference in 
Childhood diabetes, International Journal of Diabetes in Developing Countries - 1996.
In a study done at institute of child health, Sengottuvel et al., the incidence of Juvenile 
diabetes in the age group 11 - 15 yrs was 72.6%28.
The incidence shows geographic variation with very low incidence at china and some 
parts of South America. Family history of diabetes was present in 20 patients (13%).
Positive history in father in 7 cases (4.7%). mother 5 - cases 3.3%).
In the EURODIAB survey the risk for a type 1 diabetic mother of having a child with 
diabetics before the age of five was 1.8% and for father 3.4%.
The usually reported figures are 6 - 8% for fathers 2-4% for mother 6 - 12% if both have 
diabetes clinical features at the time of diagnosis.
The most common presentation is rapid weight loss with polyuria, nocturia, polydipsia, 
and overwhelming fatigue. In my study 65 patients had the above symptoms for which they 
were diagnosed to have type - 1 DM.
The next common mode of presentation was fever due to respiratory and urinary tract 
infection, 9 patients in my study has tuberculosis at the time of diagnosis.
If the diagnosis is not made at an early stage symptoms worsen, with development of 
abdominal pain, nausea, vomiting, dehydration and signs of acidosis.
In my study 22 patient were diagnosed to have of ketocidosis at the time of diagnosis.
Acute complications
Both acute and chronic complication reduce life  span by 1/3 rd. Diabetic ketoacidosis 
continue to be the important cause of morbidity and 5-10% of  mortality29.
In my study 49 patient had at least one episode suggestive of ketoacidosis in which 22 
patients had ketoacidosis at the time of diagnosis.
On enquiring the patients it was found that the patients were not taking treatment with 
insulin regularly.
Infection is an other important cause that precipitates ketoacidosis, myocardial infarction 
a minor role.
In about 40% of patients in a study of Birmingham UK, the precipitating factor could 
not be identified30.
The incidence of ketoacidosis has decreased markedly in the recent past due to effective 
diagnosis and early management. There is also an increased awareness among type 1 diabetic 
patients.
Hypoglycemia is an another important complication, It is a major factor in preventing 
the patients from achieving near normal glucose targets. Nocturnal hypoglycemia may cause 
death undisturbed in bed31. The much of the epidemiological data undertaken in 1980s showed 
hypoglycemic side effects of intensive insulin therapy.
In  DCCT  of  those  randomly  assigned  to  standard  insulin  therapy,  around  10% 
experienced at least one episode of hypoglycemia over a period of 12 months.
In my study 86 persons had at least one episode of hypoglycemia, which constituted 
about 57%.
Most of the patient had history of not taking food after insulin therapy. Few of them had 
a strenous workout or exertion.
The factor that precipitate hypoglycemia include over dosage, associated renal failure, 
rapid absorption, as in abdomen injection. Counter regulatory hormone deficiency which may 
occur  following  exercise  or  postpartum  inadequate  food  intake  and  certain  drugs  (e.g 
pentamidine, salicylates, Beta Blockers).
Body mass index BMI was normal in 118 patient19. Of them were under weight and 13 
over weight obesity plays a major role in type 2 DM only.
Hypertension is more common in diabetic people than in general population affecting 10 
- 30%. of type 182 diabetic patient there are racial and ethnic difference in the prevalence of 
hypertension less common among native and Mexican Americans33 Haffners mitchell B, Stern 
et al study proved this.
There is an increased association of hypertension with nephropathy in type  1 patients.
In my study 30 patients had hypertension which is about 20%. As the duration of disease 
increase the chance of getting hypertension is more. 65% of patient who has duration of more 
than 10 yrs developed hypertension with most of them having coexisting nephropathy.
Diabetic  neuropathy  occurs  in  both  acute  and  chronic  form.  The    prevalence  of 
neuropathy was 52% in those over 10 yrs of disease and 59% in those over 15 Yrs of disease 
duration.
In Diamond study of complication (Diacomp) there was high icidence of neuropathy34 
59%  in  Puerto  Rico  and  in  Eastern  Europe.  The  EURODIAB  IDDM complication  study 
showed in Eastern  Europe it was 46.4% with a mean duration of 14.2 years and north western 
europe 24.9%, mean duration 15.4 years.
Retinopathy is found in almost all individuals who have diabetes for > 20 years 25% 
incidence with 5 years and 80% incidence with 15 years of type 1 diabetes.
In my study there was gradual increase in retinopathy as the duration increase. It was 
14% with a mean duration of 7 years. It is 52% with a mean duration of 13 years. In persons  
with duration more than 16 yrs the prevalence was 72.%.
The  study  show  an  association  between  Retinopathy  and  hypertension,  Out  of  31 
persons  with  retinopathy  24  had  hypertension.  6  persons  with  hypertension  showed   no 
evidence of retinopathy.
The annual incidence of diabetic nephropathy in type 1 reaches a maximum of 3% after 
15 yrs and declines to less than 1% after 30 years35 as observed by Andersen et al nephropathy 
in type 1 diabetes an epidemiological study. The cumulative risk is 25 - 30%. Hanscn HP. Lund 
Rossing et al. my study showed diabetic nephropathy in 63% of patients with duration more 
than 16 years, the prevalence was 42% with a mean duration at 12.5 yrs.
The study included patient with both incipient and overt nephropathy, in which incipient 
nephropathy may revert to normal, or progress to overt nephropathy.
EURODIAB  study  did  not  demonstrate  a  great  degree  of  variation.  It  showed  a 
prevalence of 25% in those with < 5 years of disease duration  Diacomp study showed 55% in 
those with duration of 5 - 9 yrs.
In my study which had 25 patients  with nephropathy 21 had hypertension.  In  some 
patients  the  AER remain  normal  even  several  years  after  diagnosis  a  study.  Lind,  Jensen 
Deckert36 et al., showed this.
Another study showed 6 - 19% of microalluminuria in 1-5 years of disease duration 
warram, Gearin Latel et al.
Dyslipidemia with increased production of VLDL and TGL and decreased production of 
HDL occurs in diabetes. Dyslipidemia may lead on to macrovascular disease mainly CAD and 
priority must be given to prevent CAD. The study had 4 patients with coronary artery disease 
and 2 with peripheral  vascular disease no one had CVA. 
Good  glycemic  control,  prevents  the  micro  and  macrovascular   complications. 
Reduction  of  HbA1c  by  1%  reduces  microvascular38 complication  by  37%,  myocardial 
infarction by 14%, risk of death related to diabetes decreased by 21%.  
A person with HbA1c of less then 7% is said to have good glycemic control, 7% A/c 
correlates to 170 mg% and 8% to 205 mg%39.
10 person with poor glycemic control had two or more microvascular complications.
24  person  had  moderate  control  and  most  of  them  had  atleast  one  microvascular 
complications.
However that only one HbA1c measurement is unlikely to reflect glycemic control over 
long periods.
In my study 25 patients had micro albuminuria in which 17 had micro albuminuria and 7 
marcoalbuminuria or clinical  proteinuria.  All these were categorised as having neprhopathy 
either incipient or overt nephropathy. Patients with microalbuminuria may progress to clinical 
proteinuria or revert back to normal.
However   micro  albuminuria  may  also  occur  in  some  other  conditions  which  may 
include infection which where not excluded in the study.
There was not much significance in the prevalence of macrovascular complication, as 
the duration of is about 20 years only.
Although  the  study  has  showed  the  approximate  prevalence  of  complication,  move 
sophisticated investigation and appropriate  clinical  examination should be done to find the 
accurate prevalence rate of the complications. 
CONCLUSION
Study population consisted of 150 type 1 diabetes patients selected randomly at Chennai.
* Age of diagnosis for most of them was between 11 - 15 years. 42% of the study group 
followed by 16 - 20 years, 34%.
* Initial mode of presentation was polyuria nocturia polydipsia polyphagia and excessive 
fatiguability and weight loss in majority of them 65 patients (44%) which formed 44% 
of the study population.
22 of the patients presented with ketoacidosis. 
Tuberculosis as a complication of diabetes was found in 9 patients.
Acute complications like ketacidosis and hypolycemia were present in 49 and 86 patient 
respectively at least once in their life time.
Positive family history present in 20 patients.
Prevalence of microvascular compliaction and hypertension increases as the duration of 
disease is more.
Microvascular complication were found in patients with a prolonged disease duration 
combined with a poor glycemic control.
Retinopathy being more common with increased duration.
The prevalence of nephropathy and neuropathy is also high.
Complications
No. of patient in the 
duration of disease 10-
15 years
No. of patient in the 
duration of disease > 16 
years
Hypertension 10 (47%) 17(77%)
Neuropathy 11(52%) 13(59%)
Retinopathy 11(52%) 16(72%)
Nephropathy 9(42%) 14(63%)
There was a co-existence of hypertension, retinopathy and rephropathy in most of the 
patient, with a longer duration of disease.
ABSTRACT
To study the prevalence of complications in type 1 diabetesmellitus and clinical feature 
of type 1 diabetes.
Randomly  selected  150  patient  who  were  diagnosed  before  25  years  of  age  were 
assessed by detailed history elicitation and clinical examinations laboratory analysis was done 
for  renal  function  test  including  albuminuria  and  for  glycemic  control  and  non  invasive 
investigation like Echo cardiogram, ultrasound and roentgenogram.
There is increased prevalence of micro vascular complication as the duration of disease 
increased.
There  was  also  different  mode  of  initial  presentation,  with  coexistent  findings  of 
hypertension with microvascular complications.
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ABBREVIATION
DM - Diabetes mellitus
OGTT - Oral glucose tolerance test
WHO - World health organisation
HLA - Human Leucocyte antigen
LADA - Late onset diabetes in adults
CNS - Central nervous system
FFA - Free Fatty acids
DICA - Diabetic Ketoacidosis
IRMA - Intra retinal microvascular abnormality
ESRD - End stage renal disease
VLDL - Very low density lipoprotein
LDL - Low density lipoprotein
NEFA - Non esterified fatty acids
HT - Hypertension
CAD - Coronary artery disease
UTI - Urinary tract infection 
BMI - Body man index
HDFP - Hypertension detection and followup programme
MNSI - Michigan neuropathy screening instrument
CVAT - Cerebrovascular accident 
KEYS
F/H - Family history
BMI - Body mass index
1 - Normal weight
2 - Under weight
3 - Over weight
CAD - Coronary artery disease
PVD - Peripheral vascular disease
Glycemic Control
1 - Good
2 - Optimum
3 - Poor
Urine albumin 
N - Normal
MA - Micro albuminuria
CP - Clinical proteinuria
+ - Present
– - Absent
PROFORMA
CLINICAL FEATURES OF TYPE 1 DIABETES MELLITUS AND PREVELANCE OF 
ITS COMPLICATIONS
Name :
Age :
Sex :
IP / OP Number :
Address :
HISTORY
1. Age of diagnosis :
2. Cause for detection :
3. Ketosis proneness :
4. Hypoglycemia 
proneness :
5. Duration :
6. Family history of
diabetes :
7. Obstetrics history :
8. Smoking :
9. Alcoholism :
PHYSICAL EXAMINATION
1. Height
2. Weight
3. Body Mass Index
4. Pulse Right Left
Carotid
Brachial
Radial
Femoral
Pepliteal
Posterial tibial
Dorsalis pedis
5. BP
Lying
Standing
6. Thyroid enlargement
7. Balanoposthitis
8. Cardiovascular system
9. Respiratory system
10. Abdomen
11. Neurological
Higher functions
Cranial nerves
Motor system
Deep tendon reflex
Sensory 
Pain, touch, temperature
Vibration, joint position
12. Fundoscopy
INVESTIGATIONS
1. Plasma glucose F/PP
2. Urine sugar
3. Microalbuminuria / clinical protenuria
4. Urine acetone
5. Blood urea
6. Serum creatinine
7. Serum electrolytes
Na+
K+
HCO3
C1-
8. Lipid profile
Total cholesterol
Triglycerides
HDL
LDL
VLDL
9. Glycosylated Haemoglobin A1c
10. Chest X-ray PA view
11. ECG
Ultrasonogram
